abstract |
OF THE DISCLSOURE This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in 5 combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer. 11564650_1 (GHMatters) P90981.AU.4 |